3 High-Yield Financial Stocks to Buy in October

With the 10-year Treasury yield near 5.3%, the article highlights Ares Capital, Brookfield Asset Management, and Strategy's STRF preferred shares as income investments positioned to withstand elevated rates. Ares offers a 10% forward yield, supported by expected 2027 EPS of $1.93 versus a $1.92 annual dividend; Brookfield's 4.5% yield is supported by projected 14%-17% growth in 2026 fee-related earnings per share to $2.10-$2.15. Strategy's senior STRF preferred shares pay a cumulative fixed 10% dividend and have gained 13% since launch, though their returns and dividend funding remain linked to the company's Bitcoin strategy.

Analysis

ARCC's equity duration is shorter than banks' because much of its asset book reprices with base rates, but the relevant risk is now borrower coverage rather than net interest income. With virtually no projected dividend-coverage cushion, even modest non-accrual growth or a mark-down in sponsor-backed middle-market credits can force supplemental-distribution pressure and NAV erosion; spreads, not Treasury yields alone, should drive the position. The second-order beneficiary of sustained private-credit demand is ARES, whose fee stream scales without ARCC's direct credit-loss exposure.

BAM offers the cleaner rate trade versus BN: fee-related earnings can compound through fundraising and deployment while BN retains the balance-sheet, refinancing, and asset-valuation sensitivity. The near-term issue is fundraising pacing—higher-for-longer rates can delay institutional commitments and realizations—so 1-3 month upside needs evidence of fee-bearing capital growth rather than a generic dividend bid. Over 6-18 months, a reopening in private-market exits would improve BAM's carried-interest optionality and likely narrow its valuation discount to alternative-asset-manager peers.

STRF is not a conventional income security; its credit quality is a leveraged function of BTC volatility, Strategy's capital-markets access, and preferred issuance hierarchy. A fixed coupon can look attractive until BTC weakness closes the equity/preferred issuance window, at which point cumulative dividends preserve a claim but do not eliminate duration, liquidity, or restructuring risk. Consensus income screens underprice this path dependency; STRF should be sized as crypto credit, not as a substitute for high-grade yield.

Key Decisions for Investors

• Prefer a 3-6 month long BAM / short BN pair. This isolates the asset-light fee model from Brookfield's asset-heavy funding exposure; target a 10-15% relative move, and exit if BAM reports decelerating fee-bearing capital or BN's financing-cost outlook improves materially.
• Maintain ARCC only as a monitored income exposure, not a new aggressive long. Add only after quarterly non-accruals, realized losses, and NAV per share confirm stable credit; reduce if NAV declines more than 2% sequentially or regular dividend coverage falls below 1.0x.
• For private-credit beta, favor long ARES over ARCC on a 6-18 month horizon if fundraising remains resilient. ARES captures management-fee growth while avoiding direct balance-sheet loss severity; invalidate on weaker net inflows or material fee-related earnings-guide cuts.
• Avoid initiating STRF solely for yield. For investors seeking BTC-linked upside, use a small, defined-risk position only after confirming its trading liquidity and yield-to-call metrics; hedge with BTC downside protection or cap exposure. A sustained BTC drawdown of 30%+ and reduced Strategy capital-markets access are the key thesis-break risks.